DTIL Earnings & Financial Statements
Precision BioSciences, Inc.
$6.17
+$0.14(+2.32%)
39
Overall
55
Value
20
Tech
42
Quality
Market Cap
$166.44M
Volume
246.14K
52W Range
$3.53 - $9.62
Target Price
$29.40
DTIL earnings and financial statements: Precision BioSciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
DTIL Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $34.26M | $68.70M | $48.73M | $25.10M | $115.53M |
| Operating income | -$52.15M | -$26.16M | -$43.74M | -$62.31M | -$39.38M |
| EBITDA | -$41.33M | $13.77M | -$35.25M | -$62.79M | -$20.27M |
| Net income | -$45.72M | $7.17M | -$61.32M | -$72.91M | -$30.60M |
| EPS (diluted) | $-3.56 | $1.04 | $-15.96 | $-38.10 | $-15.60 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $154.42M | $136.39M | $159.78M | $238.17M | $211.50M |
| Total liabilities | $62.17M | $80.00M | $140.92M | $177.74M | $120.33M |
| Shareholders’ equity | $92.25M | $56.39M | $18.86M | $60.43M | $91.17M |
| Cash and equivalents | $110.82M | $85.90M | $116.68M | $189.58M | $143.66M |
| Long-term debt | $4.90M | $6.40M | $7.72M | $23.28M | $7.29M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$65.84M | -$58.45M | -$84.11M | -$45.75M | -$10.85M |
| Capital expenditure | -$19.0K | -$190.0K | -$2.28M | -$3.32M | -$5.80M |
| Free cash flow | -$65.93M | -$58.70M | -$86.39M | -$49.07M | -$16.66M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DTIL | $6.17 | +2.3% | 246.14K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Precision BioSciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW